← Back
$TBPH All transactions

Theravance Biopharma, Inc.

G

$ Value

$0

Shares

9,900

Price

$0

Filed

Nov 21

Insider

Name

Winningham Rick E

Title

CHIEF EXECUTIVE OFFICER

CIK

0001302443

Roles

Director Officer

Transaction Details

Transaction Date

2025-11-19

Code

G

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

23,400

Footnotes

Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian. | The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose. | Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.

Filing Info

Accession No.

0001302443-25-000008

Form Type

4

Issuer CIK

0001583107

Winningham Rick E's History

Date Ticker Type Value
2026-04-01 TBPH A $0
2025-11-20 TBPH F $1.0M
2025-11-19 TBPH G $0
2025-11-19 TBPH G $0
2025-11-18 JAZZ $995K
2025-08-20 TBPH F $206K
2025-08-08 JAZZ F $201K
2025-08-07 JAZZ A $0
2025-06-23 TBPH G $0
2025-06-13 TBPH G $0

Other Insiders at TBPH (90d)

Insider Bought Sold Last
Winningham Rick E
CHIEF EXECUTIVE OFFICER
2026-04-01
Farnum Rhonda
SVP, COMM & MEDICAL AFFAIRS
2026-04-01
Sawaf Aziz
SVP & CHIEF FINANCIAL OFFICER
2026-04-01
Grimaud Brett A.
SVP, GEN COUNSEL AND SECRETARY
2026-04-01